Charlie Vandis
Chief Credit Officer at Hercules Capital
New York City, New York
Charlie Vandis, Chief Credit Officer at Hercules Capital is an active investor based in New York City, New York. This profile covers what Charlie Vandis backs, at which stage, and how founders can reach out in 2026.
- Investor type
- Venture Debt
- Stages
- Series BLate Stage Venture
- Invests in
- Lending & CreditFintechBiotech & PharmaMedTech & Medical DevicesManufacturing & IndustrialEdTech
- Location
- New York City, New York
- Typical check
- $5M
- Past investments
- 91
Notable investments
CapLinked
Melinta
ChromaDex
AMSC
UdacityNeos TherapeuticsMerrimack Pharmaceuticals
Constellation Pharmaceuticals
CytRx
Antares Pharma
Asensus Surgical
Aprecia PharmaceuticalsHow to reach Charlie Vandis
Angels and operators like Charlie Vandis reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Charlie Vandis
Frequently Asked Questions
What does Charlie Vandis invest in?
Charlie Vandis invests in Lending & Credit, Fintech, Biotech & Pharma and MedTech & Medical Devices, typically at Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Charlie Vandis invest at?
Charlie Vandis typically invests at Series B and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Charlie Vandis's typical check size?
Charlie Vandis typically writes checks around $5M. Use it as a signal for whether your raise fits their stage.
How do I contact Charlie Vandis?
Unlock Charlie Vandis's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.